Management of relapsed and refractory Hodgkin's disease
- 31 July 1996
- journal article
- Published by Elsevier in Seminars in Radiation Oncology
- Vol. 6 (3) , 210-224
- https://doi.org/10.1016/s1053-4296(96)80017-8
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- High-dose chemotherapy and radiotherapy with bone marrow transplantation in the management of the non-Hodgkin's lymphomasSeminars in Radiation Oncology, 1995
- Autologous Stem Cell Transplantation as Adjuvant Treatment vs No Further Therapy for Poor-Risk Hodgkin's Disease in First Complete Remission after MOPP/ABVDLeukemia & Lymphoma, 1995
- Marrow Transplantation for Hodgkin's Disease: Points to PonderLeukemia & Lymphoma, 1995
- Promotion of megakaryocyte progenitor expansion and differentiation by the c-Mpl ligand thrombopoietinNature, 1994
- Experimental Treatment of Human Hodgkin's Disease with Ricin A-Chain ImmunotoxinsLeukemia & Lymphoma, 1994
- Identification of Risk Factors in Patients Treated for First Relapse of Hodgkin's DiseaseLeukemia & Lymphoma, 1994
- Chemotherapy versus radiotherapy in early-stage Hodgkin's disease: Evidence of a more difficult rescue for patients relapsed after chemotherapyEuropean Journal Of Cancer, 1992
- Treatment of Resistant Hodgkin’s Disease with CCNU, Etoposide and Prednimustine (CEP)Oncology, 1991
- Wide-field radiation therapy plus simultaneous chemotherapy for refractory Hodgkin's diseaseMedical and Pediatric Oncology, 1989
- Clinical studies of autologous bone marrow transplantation in Hodgkin's diseaseClinics in Haematology, 1986